首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Further development of local IL-2 therapy of cancer: multiple versus single IL-2 treatment of transplanted murine colon carcinoma
Authors:Halina?Kusnierczyk  Elzbieta?Pajtasz-Piasecka  Jan-Willem?Koten  Caspaar?Bijleveld  Krzysztof?Krawczyk  Email author" target="_blank">Willem?Den?OtterEmail author
Institution:(1) Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Rudolfa Weigla St. 12, 53-114 Warsaw, Poland;(2) Department of Cell Biology and Histology, PO Box 80.176, 3508 TD Utrecht, The Netherlands;(3) Department of Veterinary Pathology, Utrecht, The Netherlands;(4) Institute of Molecular Biology, Jagiellonian University, 3 Mickiewicz Ave., 31-120 Krakow, Poland
Abstract:We have compared the effect of one and up to four local IL-2 treatments of transplanted MC38 colon carcinoma. A single IL-2 treatment prolonged the survival time (p=0.015), but no cure was obtained. One local IL-2 treatment inhibited tumor growth for about 1 week. After the start of tumor regrowth, a further IL-2 injection was given. After four IL-2 injections 6 out of 13 mice were cured. Histological studies show that IL-2 induced a local vascular leakage syndrome leading to massive peritumoral edema and subsequent necrosis of tumor tissue. IL-2 also attracted infiltrating cells, mainly macrophages. Subsequent IL-2 injections led to complete tumor regression. We believe that the combination of necrotic tumor debris and the IL-2–induced macrophage reaction enhanced a tumor-specific immune response. This local IL-2 application was not toxic.
Keywords:Colonic neoplasms  Colonic neoplasms / drug therapy  Interleukin-2 / therapeutic use  Neoplasms/therapy  Pathology
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号